Strategies for stroke prevention in atrial fibrillation.
Chung
Mina K
MK
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Ohio 44195, USA. chungm@ccf.org
Burkhardt
J David
JD
Klein
Allan L
AL
D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000628:therapy; D021721:Balloon Occlusion; D004554:Electric Countershock; D006325:Heart Atria / Q000601:surgery; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D020521:Stroke / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D001241:Aspirin